You have 9 free searches left this month | for more free features.

PNET

Showing 1 - 25 of 146

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)

Completed
  • Metastatic Medulloblastoma
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
Dec 13, 2021

Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

Recruiting
  • Pancreatic Neuroendocrine Tumor
  • peptide receptor radionuclide therapy with Y-90-DOTATOC
  • Milano, Italy
  • +1 more
Sep 30, 2022

Rare CNS Tumors Outcomes &Risk

Recruiting
  • High Grade Meningioma
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Radiation Therapy in Pediatric Central Nervous System Tumors

    Completed
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Pancreatic Neuroendocrine Tumors Trial in Beijing, Shanghai, Guangzhou (everolimus)

      Active, not recruiting
      • Pancreatic Neuroendocrine Tumors
      • Beijing, Beijing, China
      • +3 more
      Sep 27, 2021

      Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

      Active, not recruiting
      • Supratentorial Neoplasms, Malignant
      • +6 more
      • G207
      • Birmingham, Alabama
      • +1 more
      Jun 1, 2022

      Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

      Recruiting
      • Ewing's Family Tumors
      • +11 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Apr 11, 2022

      Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Carcinoma Trial in United States

      Completed
      • Pancreatic Alpha Cell Carcinoma
      • +4 more
      • Chicago, Illinois
      • +4 more
      Jul 14, 2021

      Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)

      Recruiting
      • Pheochromocytoma/Paraganglioma
      • +2 more
      • Los Angeles, California
      • +58 more
      Jan 27, 2023

      Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

      Recruiting
      • Neuroendocrine Tumor of Pancreas
      • Multiple Endocrine Neoplasia Type 1
      • High-dose-high precision MR-guided radiotherapy
      • Utrecht, Netherlands
        UMC Utrecht
      May 29, 2022

      Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma Trial in France (Blood sampling to build population

      Recruiting
      • Digestive Cancer
      • +4 more
      • Blood sampling to build population pharmacokinetics model
      • Auxerre, France
      • +23 more
      Aug 30, 2022

      Prognosis Between Pancreatic Neuroendocrine Tumors and

      Completed
      • Neuroendocrine Tumor of Pancreas
      • +2 more
      • No intervention
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital of Zhejiang University School of Medi
      Jul 25, 2021

      Childhood Brain Tumor Trial in Germany

      Active, not recruiting
      • Childhood Brain Tumor
        • Aachen, Germany
        • +55 more
        Apr 11, 2022

        d to Developing Multiple Endocrine Neoplasia and Pancreatic

        Recruiting
        • Multiple Endocrine Neoplasia
        • +2 more
        • Genome Sequencing
        • Data Review
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Sep 11, 2019

        18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas

        Withdrawn
        • Ependymoma
        • +4 more
          • (no location specified)
          Dec 11, 2019

          Neuroendocrine Tumors, Pancreatic Tumors Trial in Spain (TH-302 + Sunitinib)

          Completed
          • Neuroendocrine Tumors
          • Pancreatic Neoplasms
          • TH-302 + Sunitinib
          • L'Hospitalet de Llobregat, Barcelona, Spain
          • +9 more
          Jul 9, 2020

          Tumors Trial in Italy, United States (surufatinib)

          Completed
          • Tumors
          • Los Angeles, California
          • +11 more
          Jan 11, 2023

          Inpatient Hospice With Procurement of Brain Tumor Tissue on

          Terminated
          • Ependymomas
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Nov 30, 2019

            Overall and Disease Specific Survival in Confirmed MEN1 With or

            Active, not recruiting
            • Genetic Mutation
            • MEN1
            • Chart Review
            • Questionnaire
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            May 21, 2019

            Medulloblastoma, Pontine Glioma, Ependymoma Trial run by the NCI (Temozolomide, ABT-888)

            Completed
            • Medulloblastoma
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Dec 6, 2019

            Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

            Active, not recruiting
            • Carcinoid Tumor
            • Pancreatic Neuroendocrine Tumor
            • Boston, Massachusetts
            • +1 more
            Jul 15, 2022

            Sunitinib In Chinese Progressive Advanced Or Metastatic

            Active, not recruiting
            • Pancreatic Neuroendocrine Tumors
            • Hefei, Anhui, China
            • +15 more
            Oct 19, 2021

            CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

            Available
            • Central Nervous System/Leptomeningeal Neoplasms
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Jul 15, 2022

            Anaplastic Medulloblastoma, Medulloblastoma Trial in Worldwide (drug, biological, other, radiation)

            Active, not recruiting
            • Anaplastic Medulloblastoma
            • Medulloblastoma
            • Birmingham, Alabama
            • +195 more
            Jan 4, 2022